查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813791

人工心臟瓣膜市場規模、佔有率和趨勢分析報告：按瓣膜、材料、最終用途、地區和細分市場預測，2025-2033 年

Prosthetic Heart Valve Market Size, Share & Trends Analysis Report By Valve (Transcatheter Heart Valves, Bioprosthetic Valves, Mechanical Valves), By Material, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

人工心臟瓣膜市場摘要

2024 年全球人工心臟瓣膜市場價值估計為 96.4 億美元，預計 2033 年將達到 206.9 億美元，2025 年至 2033 年的複合年成長率為 8.7%。

心臟瓣膜疾病數量的增加推動了市場的成長

根據 2024 年 12 月發表的 NCBI 論文，最近的估計表明，約有 5,480 萬人患有風濕性心臟疾病(RHD)，置信區間為 4,330 萬至 6,760 萬。此外，非風濕性鈣化性主動脈瓣疾病 (CAVD) 影響全球約 1,330 萬人，而非風濕性退化性二尖瓣疾病 (DMVD) 約佔全球病例的 1,550 萬人。這些疾病是結構性瓣膜功能障礙的主要原因之一，通常需要手術或經導管瓣膜置換術。此外，風濕性和退化性瓣膜疾病在不同年齡層和地區的盛行率高且不斷上升是推動市場擴張的關鍵因素。

心臟瓣膜疾病的發生率不斷上升，尤其是在老年人中，這是人工心臟瓣膜置換術（包括手術和經導管方法）廣泛應用的一個主要因素。主動脈瓣狹窄和二尖瓣瓣膜閉鎖不全等退化性疾病日益普遍，推動了對人工瓣膜植入等有效干預措施的需求。根據 2024 年 CDC 的一份報告，四分之三的美國成年人對心臟瓣膜疾病的認知較低，尤其是 65 歲及以上的人。每年有超過 500 萬美國人被診斷出患有心臟瓣膜疾病，每年導致超過 25,000 人死亡。這些數字凸顯了加強教育、早期診斷和擴大人工心臟瓣膜治療機會的迫切需求。

政府資助和宣傳宣傳活動正在推動人工心臟瓣膜產業的發展。根據美國心臟協會（美國 Heart Association, Inc.）2024年10月發表的報導，美國疾病管制與預防中心（CDC）向美國心臟協會津貼840萬美元，用於開展一項以心臟瓣膜疾病教育為重點的全國性宣傳活動。這些舉措包括針對患者、醫療保健提供者以及女性（一個服務不足的高風險群體）的教育推廣。該計畫源自於兩黨共同製定的《優先研究和宣傳心臟瓣膜疾病法案》（CAROL法案），該法案於2022年12月簽署生效。

與傳統的開心手術相比，包括經導管瓣膜置換術(TAVR) 在內的微創手術由於恢復時間更短、併發症風險更低、整體醫療成本更低而越來越受歡迎。這種向非侵入性手術的轉變是推動市場發展的關鍵因素。 2024 年 4 月，雅培宣布 FDA核准TriClip 系統，這是一種用於治療瓣膜閉鎖不全(TR) 的經導管邊對邊修復技術。這款世界首創的裝置可實現微創治療，並改善患者預後，無需進行高風險的開心手術。臨床試驗表明，使用 TriClip 的患者 TR 嚴重程度和生活品質得到顯著改善。

經導管心臟瓣膜 (THV) 設計的技術進步是推動市場成長的關鍵因素，包括提高瓣膜耐用性、易於植入和改善患者預後。影像處理技術和瓣膜輸送系統的進步也顯著提高了手術成功率，擴大了適合 THV 手術的患者群體。 2024 年 8 月，波士頓科學公司宣布其 ACURATE Prime 主動脈瓣系統獲得 CE 標誌核准。這種尖端的經導管主動脈瓣置換系統採用新的瓣膜尺寸，以適應較大的患者解剖結構。它適用於患有嚴重主動脈瓣狹窄的低風險、中度風險和高風險患者。該系統採用自擴張設計和先進的部署機制，提高了瓣膜定位精度並改善了患者的整體預後。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章全球人工心臟瓣膜市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 補貼市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 全球人工心臟瓣膜市場分析工具
    • 產業分析-波特五力分析
    • PESTLE分析
  • 技術格局
  • 案例研究分析

4. 全球人工心臟瓣膜市場細分分析（依瓣膜分類），2021-2033 年

  • 定義和範圍
  • 2024年及2033年閥門市佔率分析
  • 細分儀表板
  • 全球人工心臟瓣膜市場（按瓣膜，2021-2033 年）
  • 經導管心臟瓣膜
    • 經導管心臟瓣膜市場估計與預測（2021-2033年）
  • 生物瓣膜（組織瓣膜）
    • 生物瓣膜（組織瓣膜）市場預測與預測（2021-2033年）
    • 支架
    • 異種移植
    • 無支架
    • 同種異體移植
  • 機械閥
    • 機械瓣膜市場估計與預測（2021-2033年）
    • 斜盤閥
    • 球籠閥

5. 2021-2033 年全球人工心臟瓣膜市場細分分析（依資料）

  • 定義和範圍
  • 2024年及2033年材料市佔率分析
  • 細分儀表板
  • 全球人工心臟瓣膜市場（依材料分類）（2021-2033）
  • 生物組織
    • 2021-2033年生物組織市場估計與預測
  • 熱解碳
    • 2021-2033年熱解碳市場估計與預測
  • 金屬合金
    • 2021-2033年金屬合金市場估計與預測
  • 聚合物
    • 2021-2033年聚合物市場預測

6. 全球人工心臟瓣膜市場細分分析（依最終用途），2021-2033

  • 定義和範圍
  • 2024年及2033年最終用途市佔率分析
  • 細分儀表板
  • 2021-2033年全球人工心臟瓣膜市場（依最終用途）
  • 醫院
    • 2021-2033年醫院市場估計與預測
  • 門診手術中心
    • 2021-2033年門診手術中心市場估計與預測
  • 其他
    • 2021-2033年其他市場估計與預測

7. 2021-2033 年人工心臟瓣膜市場細分分析（按地區）

  • 2024 年及 2034 年區域市佔率分析
  • 區域市場儀表板
  • 區域市場概況
  • 2024 年及 2033 年各地區人工心臟瓣膜市場佔有率：
  • 北美洲
    • 2021-2033年北美人工心臟瓣膜市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2021-2033年歐洲人工心臟瓣膜市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司簡介
    • Edwards Lifesciences
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corp.
    • CryoLife, Inc.（now Artivion）
    • MicroPort Scientific Corp.
    • Lepu Medical Technology（Beijing）Co.,Ltd.
    • Venus Medtech（Hangzhou）Inc.
    • Foldax, Inc.
    • Meril Life Sciences
    • TTK Healthcare Limited
Product Code: GVR-4-68040-701-7

Prosthetic Heart Valve Market Summary

The global prosthetic heart valve market size was estimated at USD 9.64 billion in 2024 and is projected to reach USD 20.69 billion by 2033, growing at a CAGR of 8.7% from 2025 to 2033. Rising valvular heart diseases drive the growth of the market.

According to an NCBI article published in December 2024, recent estimates indicate that approximately 54.8 million people are affected by rheumatic heart disease (RHD), with a confidence range between 43.3 and 67.6 million. In addition, non-rheumatic calcific aortic valve disease (CAVD) impacts around 13.3 million individuals, while non-rheumatic degenerative mitral valve disease (DMVD) accounts for approximately 15.5 million cases globally. These conditions are among the leading causes of structural valve deterioration, often necessitating surgical or transcatheter valve replacement. Moreover, the high and growing prevalence of both rheumatic and degenerative valve disorders across diverse age groups and regions is a key factor propelling the expansion of the market.

The rising incidence of heart valve disorders, particularly among the elderly, is a key driver for the growing adoption of prosthetic heart valve procedures, including both surgical and transcatheter approaches. Degenerative conditions such as aortic stenosis and mitral regurgitation are becoming increasingly prevalent, prompting the need for effective interventions like prosthetic valve implants. According to the CDC article published in 2024, three in four adults in the U.S. have limited awareness of heart valve disease, with particularly low recognition among those aged 65 and older, ironically, the group most at risk. Annually, more than 5 million Americans are diagnosed with heart valve disease, and the condition is responsible for over 25,000 deaths each year. These figures underscore a pressing need for improved education, early diagnosis, and expanded access to prosthetic heart valve therapies.

Government funding and awareness campaigns fuel growth in the prosthetic heart valve industry. According to the American Heart Association, Inc., an article published in October 2024, the CDC awarded USD 8.4 million in grants to the American Heart Association to launch national campaigns focused on heart valve disease education. These initiatives will include educational outreach targeting patients, healthcare providers, and women, an underserved high-risk group. The program stems from the bipartisan CAROL Act, signed into law in December 2022, to prioritize HVD research and awareness.

There is an increasing demand for minimally invasive surgeries, including transcatheter valve replacement (TAVR), due to their shorter recovery times, reduced complication risks, and lower overall healthcare costs than traditional open-heart surgery. This shift towards non-invasive procedures is a critical factor propelling the market. In April 2024, Abbott announced FDA approval for its TriClip system, a transcatheter edge-to-edge repair technology for treating tricuspid regurgitation (TR). This first-of-its-kind device allows for less invasive treatment, improving patient outcomes without needing high-risk open-heart surgery. Clinical trials showed significant improvements in TR severity and quality of life for patients treated with TriClip.

Technological advancements in Transcatheter Heart Valves (THV) design, such as enhanced valve durability, ease of implantation, and better patient outcomes, are key drivers driving market growth. Advancements in imaging techniques and valve delivery systems also significantly improve procedural success and expand the patient pool eligible for THV procedures. In August 2024, Boston Scientific announced that its ACURATE Prime Aortic Valve System received CE mark approval. This state-of-the-art transcatheter aortic valve replacement system features a new valve size to serve patients with larger anatomies. It is indicated for individuals at low, intermediate, and high risk experiencing severe aortic stenosis. The system incorporates a self-expanding design and a refined deployment mechanism, enhancing valve positioning accuracy to improve overall patient outcomes.

Global Prosthetic Heart Valve Market Report Segmentation

This report forecasts revenue growth and analyzes the latest trends in each sub-segments from 2021 to 2033 at the global, regional, and country levels. For this report, Grand View Research has segmented the global prosthetic heart valve market report based on valve, material, end-use, and region:

  • Valve Outlook (Revenue, USD Million, 2021 - 2033)
  • Transcatheter Heart Valves
  • Bioprosthetic (Tissue) Valves
  • Homograft's
    • Heterografts
    • Stented
    • Stentless
  • Mechanical Valves
    • Tilting Disc Valves
    • Ball Cage Valves
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Metal Alloys
  • Pyrolytic Carbon
  • Biological Tissue
  • Polymers
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Valve outlook
    • 2.2.2. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. Global Prosthetic Heart Valve Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising valvular heart diseases
      • 3.2.1.2. Government funding and awareness campaigns
      • 3.2.1.3. Technological advancements in heart valve
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatments
      • 3.2.2.2. Regulatory challenges and approval delays
  • 3.3. Global Prosthetic Heart Valve: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Technology Landscape
  • 3.5. Case Study Analysis

Chapter 4. Global Prosthetic Heart Valve Market Segment Analysis, By Valve, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Valve Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Prosthetic Heart Valve Market, by Valve, 2021 to 2033
  • 4.5. Transcatheter Heart Valves
    • 4.5.1. Transcatheter heart valves market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Bioprosthetic (Tissue) Valves
    • 4.6.1. Bioprosthetic (Tissue) valves market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.2. Stented
      • 4.6.2.1. Stented market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.3. Heterografts
      • 4.6.3.1. Heterografts market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.4. Stentless
      • 4.6.4.1. Stentless market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.5. Homografts
      • 4.6.5.1. Homografts market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Mechanical Valves
    • 4.7.1. Mechanical valves market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.2. Tilting Disc Valves
      • 4.7.2.1. Tilting disc valves market estimates and forecasts, 2021 to 2033 (USD Million)
        • 4.7.2.1.1. CRT-Defibrillator
        • 4.7.2.1.2. CRT-Pacemakers
    • 4.7.3. Ball Cage Valves
      • 4.7.3.1. Ball cage valves market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Prosthetic Heart Valve Market Segment Analysis, By Material, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Material Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Prosthetic Heart Valve Market, by Material, 2021 to 2033
  • 5.5. Biological Tissue
    • 5.5.1. Biological tissue market estimates and forecasts, 2021 to 2033 (USD million)
  • 5.6. Pyrolytic Carbon
    • 5.6.1. Pyrolytic carbon market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Metal Alloys
    • 5.7.1. Metal alloys market estimates and forecasts, 2021 to 2033 (USD million)
  • 5.8. Polymers
    • 5.8.1. Polymers market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Global Prosthetic Heart Valve Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2024 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Prosthetic Heart Valve Market, by End Use, 2021 to 2033
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD million)
  • 6.6. Ambulatory Surgery Centers
    • 6.6.1. Ambulatory surgery centers market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2021 to 2033 (USD million)

Chapter 7. Prosthetic Heart Valve Market Segment Analysis, By Region, 2021- 2033 (USD Million)

  • 7.1. Regional Market Share Analysis, 2024 & 2034
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Prosthetic Heart Valve Market Share by Region, 2024 & 2033:
  • 7.5. North America
    • 7.5.1. North America prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Scenario
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. U.S. prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Scenario
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Canada prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Scenario
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico prosthetic heart valve market, 2021 - 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Scenario
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. UK prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Scenario
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Germany prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Scenario
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. France prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Scenario
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Italy prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Scenario
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Spain prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Scenario
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Norway prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Regulatory Scenario
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Sweden prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Regulatory Scenario
      • 7.6.9.3. Competitive Scenario
      • 7.6.9.4. Denmark prosthetic heart valve market, 2021 - 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Scenario
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Japan prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Scenario
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. China prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Scenario
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. India prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Scenario
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Australia prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Regulatory Scenario
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. South Korea prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Regulatory Scenario
      • 7.7.6.3. Competitive Scenario
      • 7.7.6.4. Thailand prosthetic heart valve market, 2021 - 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Scenario
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Brazil prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Scenario
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Argentina prosthetic heart valve market, 2021 - 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key Country Dynamics
      • 7.9.1.2. Regulatory Scenario
      • 7.9.1.3. Competitive Scenario
      • 7.9.1.4. South Africa prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Regulatory Scenario
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. Saudi Arabia prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Regulatory Scenario
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. UAE prosthetic heart valve market, 2021 - 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Regulatory Scenario
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. Kuwait prosthetic heart valve market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Profiles
    • 8.3.1. Edwards Lifesciences
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Valve benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Medtronic plc
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Valve benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Abbott Laboratories
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Valve benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Boston Scientific Corp.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Valve benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. CryoLife, Inc. (now Artivion)
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Valve benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. MicroPort Scientific Corp.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Valve benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Lepu Medical Technology(Beijing)Co.,Ltd.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Valve benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Venus Medtech (Hangzhou) Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Valve benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Foldax, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Valve benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Meril Life Sciences
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Valve benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. TTK Healthcare Limited
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Valve benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 4. Global Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 5. Global Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6. Global Prosthetic Heart Valve Market, By Region, 2021 - 2033 (USD Million)
  • Table 7. North America Prosthetic Heart Valve Market, By Country, 2021 - 2033 (USD Million)
  • Table 8. North America Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 9. North America Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 10. North America Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 11. U.S. Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 12. U.S. Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 13. U.S. Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 14. Canada Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 15. Canada Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 16. Canada Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17. Mexico Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 18. Mexico Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 19. Mexico Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20. Europe Prosthetic Heart Valve Market, By Country, 2021 - 2033 (USD Million)
  • Table 21. Europe Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 22. Europe Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 23. Europe Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 24. UK Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 25. UK Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 26. UK Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27. Germany Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 28. Germany Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 29. Germany Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30. France Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 31. France Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 32. France Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 33. Italy Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 34. Italy Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 35. Italy Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36. Spain Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 37. Spain Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 38. Spain Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 39. Denmark Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 40. Denmark Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 41. Denmark Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42. Sweden Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 43. Sweden Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 44. Sweden Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 45. Norway Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 46. Norway Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 47. Norway Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Prosthetic Heart Valve Market, by Country, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 51. Asia Pacific Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 52. Japan Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 53. Japan Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 54. Japan Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 55. China Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 56. China Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 57. China Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58. India Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 59. India Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 60. India Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61. Australia Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 62. Australia Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 63. Australia Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64. Thailand Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 65. Thailand Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 66. Thailand Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67. South Korea Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 68. South Korea Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 69. South Korea Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 70. Latin America Prosthetic Heart Valve Market, by Country, 2021 - 2033 (USD Million)
  • Table 71. Latin America Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 72. Latin America Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 73. Latin America Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74. Brazil Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 75. Brazil Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 76. Brazil Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 77. Argentina Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 78. Argentina Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 79. Argentina Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Prosthetic Heart Valve Market, by Country, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa Prosthetic Heart Valve Market, by Valve, 2021 - 2033 (USD Million)
  • Table 82. Middle East & Africa Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 83. Middle East & Africa Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 84. South Africa Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 85. South Africa Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 86. South Africa Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 90. UAE Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 91. UAE Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 92. UAE Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)
  • Table 93. Kuwait Prosthetic Heart Valve Market, By Valve, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Prosthetic Heart Valve Market, By Material, 2021 - 2033 (USD Million)
  • Table 95. Kuwait Prosthetic Heart Valve Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Global prosthetic heart valve market: outlook
  • Fig. 9 Global prosthetic heart valve competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Ancillary market outlook
  • Fig. 12 Global prosthetic heart valve market driver impact
  • Fig. 13 Global prosthetic heart valve market restraint impact
  • Fig. 14 Porter's Analysis
  • Fig. 15 PESTLE Analysis
  • Fig. 16 Global prosthetic heart valve market: Valve movement analysis
  • Fig. 17 Global prosthetic heart valve market: Valve outlook and key takeaways
  • Fig. 18 Transcatheter heart valves market estimates and forecast, 2021 - 2033
  • Fig. 19 Bioprosthetic (Tissue) valves market estimates and forecast, 2021 - 2033
  • Fig. 20 Stented market estimates and forecast, 2021 - 2033
  • Fig. 21 Heterografts market estimates and forecast, 2021 - 2033
  • Fig. 22 Stentless market estimates and forecast, 2021 - 2033
  • Fig. 23 Homografts market estimates and forecast, 2021 - 2033
  • Fig. 24 Mechanical valves market estimates and forecast, 2021 - 2033
  • Fig. 25 Tilting disc valves market estimates and forecast, 2021 - 2033
  • Fig. 26 Ball cage valves market estimates and forecast, 2021 - 2033
  • Fig. 27 Global prosthetic heart valve market: Material movement analysis
  • Fig. 28 Global prosthetic heart valve market: Material outlook and key takeaways
  • Fig. 29 Metal alloys market estimates and forecasts, 2021 - 2033
  • Fig. 30 Pyrolytic carbon market estimates and forecasts,2021 - 2033
  • Fig. 31 Biological tissue market estimates and forecasts,2021 - 2033
  • Fig. 32 Polymers market estimates and forecasts,2021 - 2033
  • Fig. 33 Global prosthetic heart valve market: End Use movement analysis
  • Fig. 34 Global prosthetic heart valve market: End Use outlook and key takeaways
  • Fig. 35 Hospitals market estimates and forecasts, 2021 - 2033
  • Fig. 36 Ambulatory Surgical Centers (ASCs) market estimates and forecasts,2021 - 2033
  • Fig. 37 Others market estimates and forecasts,2021 - 2033
  • Fig. 38 Polymers market estimates and forecasts,2021 - 2033
  • Fig. 39 Global prosthetic heart valve market: Regional outlook and key takeaways
  • Fig. 40 North America prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 U.S. prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Mexico prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Europe prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 UK prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Germany prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Spain prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 France prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Italy prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Denmark prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Sweden prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Asia Pacific prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Japan prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 China prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 India prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Australia prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 South Korea prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Thailand prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Latin America prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Brazil prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Argentina prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 MEA prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Africa prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Saudi Arabia prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 UAE prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Kuwait prosthetic heart valve market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key company categorization
  • Fig. 92 Heat map analysis 2024